Feminist language being hijacked to market medical tests Narratives around empowerment and women’s rights are being co-opted to market interventions not backed by evidence, according to new research.
GPs encouraged to upskill in opioid dependence treatment An RACGP program aims to help GPs better understand this ‘rewarding’ area of medicine and boost authorised prescriber numbers.
Consider MHT for bones: New menopause guideline Almost a decade in the making, a toolkit refresh is the first to include advice on prescribing hormone therapy specifically for bone health.
Warning over PBS nicotine patch availability Six organisations, including the RACGP, have written to Minister Butler about a ‘major threat to public health’.
Study linking HRT with dementia risk ‘unhelpful’ Experts point out that no causal relationship between menopausal hormone therapy and dementia has been established.
Emotional problems may be ADHD’s missing link The condition comes with self-control problems that affect the ability to regulate emotions, write Barbara Sahakian and Christelle Langley.
Why TSH test results can lead to over-testing, over-treatment Lifestyle review is recommended as the first intervention to reduce risk of unnecessary patient harms and resource wastage.
Debate over ‘doctor-approved’ weight loss drugs obtained online Is a GP-reviewed online questionnaire clinically sufficient to safely prescribe injectable medications without a face-to-face consultation? It depends who you ask.
Trial aims to improve therapy access for insomnia The pilot is designed to better support GPs with management, referral pathways and non-drug interventions for patients with insomnia.
In Practice: Last chance for early bird rates Discounted rates for next year’s International Medicine in Addiction conference are closing soon.